Straub Elke, Fertey Jasmin, Dreer Marcel, Iftner Thomas, Stubenrauch Frank
University Hospital Tuebingen, Institute for Medical Virology and Epidemiology of Viral Diseases, Division of Experimental Virology, Tuebingen, Germany.
University Hospital Tuebingen, Institute for Medical Virology and Epidemiology of Viral Diseases, Division of Experimental Virology, Tuebingen, Germany
J Virol. 2015 Jul;89(14):7304-13. doi: 10.1128/JVI.00616-15. Epub 2015 May 6.
Persistent infections with certain human papillomaviruses (HPV) such as HPV16 are a necessary risk factor for the development of anogenital and oropharyngeal cancers. HPV16 genomes replicate as low-copy-number plasmids in the nucleus of undifferentiated keratinocytes, which requires the viral E1 and E2 replication proteins. The HPV16 E8^E2C (or E8^E2) protein limits genome replication by repressing both viral transcription and the E1/E2-dependent DNA replication. How E8^E2C expression is regulated is not understood. Previous transcript analyses indicated that the spliced E8^E2C RNA is initiated at a promoter located in the E1 region upstream of the E8 gene. Deletion and mutational analyses of the E8 promoter region identify two conserved elements that are required for basal promoter activity in HPV-negative keratinocytes. In contrast, the transcriptional enhancer in the upstream regulatory region of HPV16 does not modulate basal E8 promoter activity. Cotransfection studies indicate that E8^E2C inhibits, whereas E2 weakly activates, the E8 promoter. Interestingly, the cotransfection of E1 and E2 induces the E8 promoter much more strongly than the major early promoter, and this is partially dependent upon binding of E2 to Brd4. Mutation of E8 promoter elements in the context of HPV16 genomes results in an increased genome copy number and elevated levels of viral early and late transcripts. In summary, the promoter responsible for the expression of E8^E2C is both positively and negatively regulated by viral and cellular factors, and this regulatory circuit may be crucial to maintain a low but constant copy number of HPV16 genomes in undifferentiated cells.
HPV16 replicates in differentiating epithelia and can cause cancer. How HPV16 maintains its genome in undifferentiated cells at a low but constant level is not well understood but may be relevant for the immunological escape of HPV16 in the basal layers of the infected epithelium. This study demonstrates that the expression of the viral E8^E2C protein, which is a potent inhibitor of viral replication in undifferentiated cells, is driven by a separate promoter. The E8 promoter is both positively and negatively regulated by viral proteins and thus most likely acts as a sensor and modulator of viral copy number.
某些人乳头瘤病毒(HPV)如HPV16的持续感染是肛门生殖器癌和口咽癌发生的必要危险因素。HPV16基因组在未分化角质形成细胞的细胞核中作为低拷贝数质粒进行复制,这需要病毒E1和E2复制蛋白。HPV16 E8^E2C(或E8^E2)蛋白通过抑制病毒转录和E1/E2依赖性DNA复制来限制基因组复制。E8^E2C表达是如何调控的尚不清楚。先前的转录分析表明,剪接后的E8^E2C RNA起始于位于E8基因上游E1区域的一个启动子。对E8启动子区域的缺失和突变分析确定了两个保守元件,它们是HPV阴性角质形成细胞中基础启动子活性所必需的。相比之下,HPV16上游调控区域的转录增强子并不调节E8基础启动子活性。共转染研究表明,E8^E2C抑制E8启动子,而E2则微弱激活E8启动子。有趣的是,E1和E2的共转染比主要早期启动子更强烈地诱导E8启动子,这部分依赖于E2与Brd4的结合。在HPV16基因组背景下E8启动子元件的突变导致基因组拷贝数增加以及病毒早期和晚期转录本水平升高。总之,负责E8^E2C表达的启动子受到病毒和细胞因子的正负调控,并且这种调控回路对于在未分化细胞中维持HPV16基因组低但恒定的拷贝数可能至关重要。
HPV16在分化的上皮细胞中复制并可导致癌症。HPV16如何在未分化细胞中将其基因组维持在低但恒定的水平尚不清楚,但可能与HPV16在感染上皮细胞基底层的免疫逃逸有关。本研究表明,病毒E8^E2C蛋白(一种未分化细胞中病毒复制的有效抑制剂)的表达由一个独立的启动子驱动。E8启动子受到病毒蛋白的正负调控,因此很可能作为病毒拷贝数的传感器和调节剂。